Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

19.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can LLMs Solve Solubility Tasks? The SoluBench Benchmark for Pure and Mixed Solvent Systems.

Journal of chemical information and modeling·2026
Same author

Dataset of solubility values for organic compounds in binary mixtures of solvents at various temperatures.

Scientific data·2026
Same author

Cone <i>p</i>-aminocalix[4]arenes enriched with 'clickable' alkyne or azide functionalities.

Beilstein journal of organic chemistry·2026
Same author

Synthesis and crystal structure of 5,17-di-amino-11-<i>tert</i>-butyl-25,26,27,28-tetra-prop-oxy-23-[(tri-phenyl-meth-yl)amino]-calix[4]arene di-chloro-methane monosolvate.

Acta crystallographica. Section E, Crystallographic communications·2026
Same author

Photoinduced Tautomerisation of ESIPT-Capable Iridium(III) Complexes with Rationally Designed Acyclic Diaminocarbene Ligands.

Inorganic chemistry·2026
Same author

Straightforward Access to Stable One-Dimensional Coordination Polymers of Iridium(III) with Bridging Triiodide Anions.

Inorganic chemistry·2025

Related Experiment Video

Updated: Apr 14, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

59.2K

Machine Learning Approach to Anticancer Activity Prediction of Transition-Metal Complexes Based on a Large-Scale

Lev Krasnov1, Dmitry Malikov1,2, Marina A Kiseleva1

  • 1N.S. Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences, Leninskii pr. 31, Moscow 119071, Russia.

Journal of Medicinal Chemistry
|April 13, 2026
PubMed
Summary
This summary is machine-generated.

We created a data-driven method to predict metal complex cytotoxicity using composition data. This approach utilizes a curated database and machine learning for efficient screening of novel compounds.

More Related Videos

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

1.0K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K

Related Experiment Videos

Last Updated: Apr 14, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

59.2K
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

1.0K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K

Area of Science:

  • Computational chemistry
  • Toxicology
  • Materials science

Background:

  • Cytotoxicity assessment of metal complexes is crucial for drug development.
  • Existing methods for predicting cytotoxicity are often limited in scope and data availability.

Purpose of the Study:

  • To develop a data-driven approach for predicting metal complex cytotoxicity based on composition.
  • To create and validate machine learning models for cytotoxicity classification.
  • To establish a comprehensive database for metal complex cytotoxicity data.

Main Methods:

  • Manual curation of experimental data to build the MetalCytoToxDB database (26,500 IC50 values, 7050 complexes, 754 cell lines).
  • Development of machine learning models for cytotoxicity prediction using metal and ligand composition.
  • External validation of the best-performing models on unseen data.
  • Exploration of multimetal prediction capabilities.

Main Results:

  • Successfully developed machine learning models to predict cytotoxicity classes for ruthenium and iridium complexes.
  • Demonstrated the potential for predicting cytotoxicity for metals with scarce experimental data.
  • Proposed a pipeline for high-throughput computational screening of ruthenium complexes.

Conclusions:

  • A straightforward, data-driven approach can accurately predict metal complex cytotoxicity.
  • The MetalCytoToxDB database and developed models facilitate AI-assisted exploration and screening.
  • This methodology can accelerate the discovery of novel metal-based therapeutics.